The COVID vaccines safety net
The need to implement rigorous post-authorisation monitoring programmes as an added safety net for COVID-19 vaccines
1st December 2020
Web Exclusives
Working together
Why combining expertise from the NHS and pharmaceutical experts will deliver better patient outcomes
30th November 2020
Pharmacovigilance in a pandemic world
Infusing automation into pharmacovigilance for COVID-19 treatments
10th November 2020
Creative med affairs and bridging the healthcare gap
Med affairs will need to take an increasingly significant role when it comes to engaging with patients and HCPs to unlock the full potential of healthcare, and creativity is the key
6th November 2020
Embracing digitalisation
Five golden rules for pharma businesses to power sales from digital and e-commerce platforms
5th November 2020
Rethinking cancer detection
Research on early cancer detection has been hamstrung by market failure. We’ve got a plan to fix it.
7th October 2020
Breaking borders
How society’s changing relationship with health will break down the wall between pharma brands and consumers
2nd October 2020
A helping hand
How artificial intelligence can help pharma companies reach new audiences
23rd September 2020
What does creativity really mean in healthcare?
And why does it matter more than ever following COVID-19?
21st September 2020
Tackling the energy challenge
Three ways to optimise energy consumption in pharma manufacturing
16th September 2020
